# Dynamic activation and dual roles of SOX9+ hepatocytes in liver regeneration under acute and chronic injury by single-cell transcriptomics

**Authors:** Junwei Zhang, Yiyao Xu, Xin Lu

PMC · DOI: 10.3389/fcell.2026.1743286 · Frontiers in Cell and Developmental Biology · 2026-02-18

## TL;DR

This study explores how SOX9+ liver cells respond to different types of liver injury, showing their roles in regeneration and chronic disease.

## Contribution

The study reveals the dynamic and context-specific roles of SOX9+ hepatocytes in liver regeneration and chronic injury using single-cell transcriptomics.

## Key findings

- SOX9+ hepatocytes show transient metabolic activation during acute liver regeneration.
- In chronic injury, SOX9+ hepatocytes expand and adopt inflammatory and wound-healing programs.
- SOX9+ hepatocytes display biphasic activation in response to acute stress and recovery.

## Abstract

SOX9+ hepatocytes, marked by progenitor-like features, have been implicated in both liver regeneration and fibrosis. This study systematically characterized the temporal and contextual roles of SOX9+ hepatocytes during acute and chronic liver injury using integrated single-cell transcriptomics.

Publicly available single-cell RNA sequencing (scRNA-seq) datasets derived from mouse liver models of partial hepatectomy (PHx) and acetaminophen-induced acute liver injury (APAP), as well as human liver tissues with nonalcoholic fatty liver disease (NAFLD), were analyzed. Data were processed using Seurat and Harmony for batch correction. Pathway enrichment analysis was performed using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene set enrichment analysis (GSEA).

Under PHx, SOX9+ hepatocytes exhibit transient metabolic activation associated with early regenerative responses and hepatocyte proliferation. In the APAP model, SOX9+ hepatocytes display a biphasic activation pattern, characterized by an early response to stress- and cytokine-associated signals followed by restoration of metabolic balance. During NAFLD progression, SOX9+ hepatocytes progressively expand and acquire transcriptional programs associated with inflammatory signaling and wound-healing processes.

Our findings highlight SOX9+ hepatocytes as a dynamic and context-dependent hepatocyte subpopulation associated with adaptive metabolic responses during regeneration and altered inflammatory and wound-healing–related programs under chronic injury.

## Linked entities

- **Genes:** SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662]
- **Chemicals:** acetaminophen (PubChem CID 1983)
- **Diseases:** nonalcoholic fatty liver disease (MONDO:0013209)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** KRT19 (keratin 19) [NCBI Gene 3880] {aka CK19, K19, K1CS}, CXCL1 (C-X-C motif chemokine ligand 1) [NCBI Gene 2919] {aka FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3}, MKI67 (marker of proliferation Ki-67) [NCBI Gene 4288] {aka KIA, MIB-, MIB-1, PPP1R105}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, ITGA6 (integrin subunit alpha 6) [NCBI Gene 3655] {aka CD49f, ITGA6A, ITGA6B, JEB6, VLA-6}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, YAP1 (Yes1 associated transcriptional regulator) [NCBI Gene 10413] {aka COB1, YAP, YAP-1, YAP2, YAP65, YKI}, TGFA (transforming growth factor alpha) [NCBI Gene 7039] {aka TFGA}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) [NCBI Gene 5562] {aka AMPK, AMPK alpha 1, AMPKa1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, SOX9 (SRY-box transcription factor 9) [NCBI Gene 6662] {aka CMD1, CMPD1, ENH13, SRA1, SRXX2, SRXY10}, MMRN1 (multimerin 1) [NCBI Gene 22915] {aka ECM, EMILIN4, GPIa*, MMRN}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}
- **Diseases:** NAFLD (MESH:D065626), cancer (MESH:D009369), Inflammatory (MESH:D007249), chronic liver disease (MESH:D008107), disease (MESH:D004194), injury (MESH:D014947), cirrhosis (MESH:D005355), metaplasia (MESH:D008679), chronic metabolic injury (MESH:D020208), metabolic steatohepatitis (MESH:D005234), acute liver injury (MESH:D017114), toxic injury (MESH:D064420), end-stage disease (MESH:D007676), acute injury (MESH:D001930), end-stage liver disease (MESH:D058625), acute toxic injury (MESH:D040701), liver injury (MESH:D017093)
- **Chemicals:** APAP (MESH:D000082), fatty acid (MESH:D005227), amino acid (MESH:D000596), APAP (-), bile acid (MESH:D001647), lipid (MESH:D008055)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956686/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956686/full.md

## References

25 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956686/full.md

---
Source: https://tomesphere.com/paper/PMC12956686